Citation Impact
Citing Papers
Role of target geometry in phagocytosis
2006 Standout
The value of prognostic indices in aplastic anaemia
1981
First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma
1995
Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma
2003
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Absence of Thrombosis in Subjects with Heterozygous Protein C Deficiency
1987
Biophysical aspects of microsphere engulfment by human neutrophils
1988
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
1997
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Neuroblastoma
2007 Standout
Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity
1995
131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status
1999
Tumor response and toxicity with multiple infusions of high dose 131I‐MIBG for refractory neuroblastoma
2004
Evaluation of semi‐quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
2006
Hemolytic-uremic syndrome
1972
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
1996 Standout
Studies of malformation syndromes of man XXXXI B: Nosologic studies in the Hanhart and the Möbius syndrome
1976
Poland syndrome in British Columbia: Incidence and reproductive experience of affected persons
1977 Standout
Mobius syndrome redefined
2003 Standout
Coagulation findings in the hemolytic-uremic syndrome of infancy: Similarity to hyperacute renal allograft rejection
1971
Aplastic Anemia
1982 StandoutNobel
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma
2004
Understanding and Managing Methotrexate Nephrotoxicity
2006
Prognostic Factors in Aplastic Anaemia
1978
Venous thrombosis: a multicausal disease
1999 Standout
The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli
1985 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of H. Wehinger being referenced
Schwere renale Methotrexat-Ausscheidungsstörung nach Hochdosis-Therapie
1994
Treatment of neuroblastoma with 131I‐metaiodobenzylguanidine: Experience of the Münster/Kassel group
1987
HÆMOLYTIC-URÆMIC SYNDROME
1968
Kiefermi�bildung und Peromelie
1970
Hämolytisch-urämisches Syndrom
1969
Latex phagocytosis by polymorphonuclear leukocytes
1976
Schwerer hereditärer Protein-C-Mangel bei einem Neugeborenen mit Purpura fulminans - erfolgreiche Behandlung mit Phenprocoumon*
1985
Hämolytisch-urämisches Syndrom (Gasser)
1968
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German neuroblastoma trial
1991
[Prognosis of panmyelophthisis: Lynch's formula].
1977